Last updated August 29, 2026
Key finding
Total sleep minutes did not differ significantly for children (B vs. A: -9.27; 95% CI [-24.88; 6.34]; p 0.26)
This study examined the impact of insulin pump treatment and continuous glucose monitoring on sleep and hypoglycemia fear in children with Type 1 Diabetes, finding no significant differences in outcomes.
Quick read
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Medium-Term (3–12 mo)
Risk of bias
Some Concerns
Save research, organize studies, and quickly find important evidence again.
Plain-language summary
A plain-language read of the study’s main message and where it applies.
Study focus
This study examined the impact of insulin pump treatment and continuous glucose monitoring on sleep and hypoglycemia fear in children with Type 1 Diabetes, finding no significant differences in outcomes.
Understanding the effects of insulin pump technology on sleep and hypoglycemia fear is crucial for managing Type 1 Diabetes in children. These findings suggest that while technology may improve diabetes management, it does not necessarily enhance sleep quality or reduce anxiety about hypoglycemia.
The study may have limited generalizability due to sample size. Outcomes measured may not capture all aspects of sleep quality. The study did not assess long-term effects of the interventions.
Published in
Publication details and source links for this paper.
Ulrike S, Gloria AA, Muriel F, et al. Impact of Insulin Pump Treatment and Continuous Glucose Monitoring on Sleep and Hypoglycemia Fear in Children with Type 1 Diabetes. Frontiers in Endocrinology. 2024;15:1419502. doi:10.3389/fendo.2024.1419502
Total sleep minutes for children did not differ significantly (B vs. A: -9.27 minutes, p 0.26).
Total sleep minutes for parents showed no significant difference (B vs. A: 5.49 minutes, p 0.46).
Daytime sleepiness and fear of hypoglycemia in both children and parents did not differ significantly between the systems.
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to Insulin pump, SAP with SmartGuard feature (Minimed 640G) and Daytime Sleepiness in Children, Fear of hypoglycemia (worry), Total sleep time measured in minutes, and 2 more.
This study contributes evidence to
Primary intervention
Insulin pump
Primary outcomes
Primary intervention
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
0
Related topics
6
Evidence pairs
0
Related studies
Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.
Primary evidence
Evidence relationship
Related evidence
Intervention
Save evidence
Outcome
Save evidence
Core evidence
The primary outcomes reported in this study.
Insulin pump → Daytime Sleepiness in Children
Insulin pump → Daytime Sleepiness in Children
Insulin pump → Fear of hypoglycemia (worry)
Insulin pump → Fear of hypoglycemia (worry)
Insulin pump → Total sleep time measured in minutes
Insulin pump → Total sleep time measured in minutes
SAP with SmartGuard feature (Minimed 640G) → Daytime Sleepiness in Parents
SAP with SmartGuard feature (Minimed 640G) → Daytime Sleepiness in Parents
SAP with SmartGuard feature (Minimed 640G) → Frequency of Coping Strategies Used by Parents to Manage Hypoglycemia Fear
SAP with SmartGuard feature (Minimed 640G) → Frequency of Coping Strategies Used by Parents to Manage Hypoglycemia Fear
SAP with SmartGuard feature (Minimed 640G) → Total sleep time measured in minutes
SAP with SmartGuard feature (Minimed 640G) → Total sleep time measured in minutes
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Insulin Delivery Systems and Daytime Sleepiness in Children, Insulin Delivery Systems and Fear of hypoglycemia (worry).
This study contributes to the evidence on the following intervention-outcome relationships.
Devices & Technology
Devices & Technology
Curated evidence collections and hubs this study is part of.
All studies measuring Daytime Sleepiness in Children
Measures Daytime Sleepiness in Children as a key outcome.
All studies measuring Fear of hypoglycemia (worry)
Measures Fear of hypoglycemia (worry) as a key outcome.
All studies on Insulin Delivery Systems
Contributes to Insulin Delivery Systems evidence base.
Latest published studies
Published within the last 2 years.
Jump to pre-filtered views in Evidence Explorer.
1 results
1 results
1 results
1 results
1 results
Generated from the study's connected evidence using Evidence Intelligence™.
Insulin Delivery Systems may improve Sleep Outcomes.
ConsistencyScore™: Results are generally consistent across studies.
Ranked evidence signals
Total sleep time measured in minutes
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on 5 supporting studies with generally consistent results and a positive effect signal.
Limitations
Current evidence does not show a clear benefit of Insulin pump for Daytime Sleepiness in Children.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Daytime Sleepiness in Children
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Current evidence does not show a clear benefit of Insulin pump for Fear of hypoglycemia (worry).
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Fear of hypoglycemia (worry)
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Current evidence does not show a clear benefit of SAP with SmartGuard feature (Minimed 640G) for Daytime Sleepiness in Parents.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Daytime Sleepiness in Parents
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Next steps
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Open broader Evidence Explorer views for this relationship.
Read related research summaries.
Focused on evidence, not advertising.
Your data is always protected.
New studies added every day.
